Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (601-650)

Previous 50   Next 50

601. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007 Jul;125(7):895-900.

602. Topalkara A, Ben-Arie-Weintrob Y, Ferry JA, Foster CS. Conjunctival Marginal Zone B-cell Lymphoma (MALT Lymphoma) with Amyloid and Relapse in the Stomach. Ocul Immunol Inflamm. 2007 Jul-Aug;15(4):347-50.

603. Durrani K, Ahmed M, Foster CS. Adamantiades-Behcet Disease: Diagnosis and Current Concepts in Management of Ocular Manifestations. Compr Ophthalmol Update. 2007 Jul-Aug;8(4):225-33.

604. Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS. Intravitreal Bevacizumab for Treatment of Uveitic Macular Edema. Ophthalmology. 2007 Aug;114(8):1574-1579.

605. Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. 2007 Sep;27(7):952-7.

606. Foster CS, Korenfeld M. New potent difluprednate advances through Phase III Studies. Ophthalmology Times 2007 Sep 15; 36-37.

607. Gallagher MJ, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster CS. Biologic Response Modifier Therapy for Refractory Childhood Uveitis. Br. J. Ophthalmol. 2007 Oct;91(10):1341-4.

608. Coma MC, Yilmaz T, Foster CS. Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand. 2007 Nov;85(7):753-5.

609. Teasley LA, Christen WG, Foster CS. Oral Non-Steroidal Anti-Inflammatory Agents in the Treatment of Chronic or Recurrent Non-Infectious Uveitis. Contemporary Ophthalmology 2007;6:11:1-8.

610. Letko E, Gurcan HM, Papliodis GN, Christen W, Foster CS, Ahmed AR. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Clin Exp Dermatol. 2007 Nov;32(6):637-41.

611. Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, Foster CS. The Characteristic Features of Optical Coherence Tomography in Posterior Uveitis. Br J Ophthalmol. 2007 Dec;91(12):1680-5.

612. Levinson RD, Foster CS, Jaffe GJ. Management of chronic uveitis. Focal Points; December 2007, Volume 25, Number 11.

613. Rao V, Gallagher MJ, Bhat P, Foster CS. Sensorineural Hearing Loss In A Patient With HLA-B27 Sclero-Uveitis. Brit Journal Ophthalmol 2008; 92;3.

614. Magee CC, Coggins MP, Foster CS, Muse VV, Colvin RB. Case records of the Massachusetts General Hospital. Case 2-2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure.N Engl J Med. 2008 Jan 17;358(3):275-89.

615. Kempen JH, Daniel E, Gangaputra S, et.al. for the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Methods for Identifying Long-term Adverse Effects of Treatment in Patients with Eye Diseases:  The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.  Ophthalmic Epidemiology. 2008 Jan-Feb;15(1):47-55.

616. Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW, Caya JG, Foster CS. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol. 2008 Feb;23(1): 35-46.

617. Sippel KC, Foster CS. Pearls for limbal stem cell autografting.  Ocular Surgery News. Feb 2008: 40.

618. Sobrin L, Huang JJ, Christen W, Kafkala C, Choopong C, Foster CS. Daclizumab for Treatment of Birdshot Chorioretinopathy. Arch Ophthalmol. 2008 Feb;126(2):186-91.

619. Hinkle DM, Foster CS. Tubulointerstitial nephritis and uveitis syndrome. Int Ophth Clin. 2008 Spring;48(2):9-13.

620. Acevedo S, Quinones K, Rao V, Cervantes-Castaneda, RA, Foster CS. Cataract Surgery in children with Juvenile Idiopathic Arthritis associated uveitis. Int Ophth Clin. 2008 Spring;48(2):1-7.

621. Sayegh RR, Ang LP, Foster CS, Dohlman. The Boston Keratoprosthesis in Stevens-Johnson Syndrome. Am J Ophthalmol. 2008 Mar;145(3):438-44.

622. Sippel KC, Foster CS. Pearls in amniotic membrane transplantation.  Ocular Surgery News. Mar 2008: 44.

623. Hatton MP, Raizman M, Foster CS. Exacerbation of Undiagnosed Ocular Cicatricial Pemphigoid After Repair of Involutional Entropion.  Ophthal Plast Reconstr Surg.  2008 Mar-Apr;24(2):165-6.

624. Hinkle, DM, Foster CS. Autoimmune Inflammatory Vitreoretinal Disease: Pathogenesis, Progression, and Treatment. Retinal Physician; April 2008.

625. Seth RK, Foster CS, Huang JJ, Scott IU, Fekrat S. Epithelial downgrowth:  A new option for an old Adversary.  Cornea; May 2008; 45-46.

626. Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS. Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm. 2008 May-Jun;16(3):89-93.

627. Sobrin L, Christen W, Foster CS. Mycophenolate Mofetil after Methotrexate Failure or Intolerance in the Treatment of Scleritis and Uveitis.Ophthalmology. 2008 Aug;115(8):1416-21, 1421.

628. Gallagher MJ, Cervantes-Castaneda R, Bhat P, Foster CS. Primary Intra-ocular lymphoma: another great masquerader. European Journal of Ophthalmology. 2008; Jul-Aug;18(4): 567-71.

629. Kempen J, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer K. Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence, Am J Ophthalmol. Volume 146, Issue 6, December 2008, Pages 802-812.

630. Foster CS. Ganciclovir Gel – A New Topical Treatment for Herpetci Keratitis. US Ophthalmic Review (Extract); Touch Briefings. 2008.

631. Callanan, DG, Jaffe, GJ, Martin, DF, Pearson, PA, Comstock, TL. Treatment of Posterior Uveitis With a Fluocinolone Acetonide Implant. Arch ophthalmol.  2008 Sep; 126(9):  1191-1201.

632. Anzaar F, Gallagher MJ, Bhat P, Arif M, Farooqui M, Foster CS. Use of Systemic T- Lymphocyte Signal Transduction Inhibitors in the Treatment of Atopic Keratoconjunctivitis. Cornea 2008 Sep;27(8):884-8.

633. Choopong, P, Tauber, J, Foster, CS. Wegener Granulomatosis. Contemporary Ophthalmology.  2008 Oct 15; 7(19): 1-7.

634. Grimm SA, Mccannel CA, Omura AM, et al. Primary CNS Lymphoma with Intraocular Involvement (short review of: Grimm SA et   Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology. 2008 Oct 21;71(17):1355-60.

635. Doctor P, Bhat P, Yilmaz T, Foster, CS. Subconjunctival bevacizumab for corneal neovascularization. Cornea 2008 Oct;27(9):992-5.

636. Iaccheri B, Fiore T, Papadaki T, Androudi S, Janjua S, Bahaila I, Foster CS. Adverse drug reactions to treatments for ocular toxoplasmosis:  A retrospective chart review.  Clinical Therapeutics.  2008 Nov;30(11):2069-74.

637. Kacmaz RO, Kempen JH, Newcomb C, et al. For the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular Inflammation in Behect’s Disease: Incidence of Ocular Complications and Loss of Visual Acuity. Am J Ophthalmol. 2008 Dec;146(6):828-36.

638. Doctor P, Bhat P, Foster CS. Peripheral Ulcerative Keratitis. Contemporary Ophthalmology. 2008 Dec 15; 7(23): 1-7.

639. Fortuna E, Cervantes-Castañeda R, Bhat, P, Doctor P, Foster CS. Flare-up rates with Bimatoprost Therapy in Uveitic Glaucoma. Am J Ophthalmol. 2008 Dec;146(6):876-82.

640. Kempen JH, Gangaputra S, Daniel E, et.al. Long-term malignancy among patients treated with immunosuprressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol.  2008 Dec; 146(6):802-12.e1.

641. Bhat P, Castañeda-Cervantes R, Doctor P, Foster CS. Intravenous daclizumab for recalcitrant ocular inflammatory disease. 2009 May;247(5):687-92.

642. Hamam R, Bhat P, Foster CS. Conjunctival/Corneal Intraepithelial Neoplasia. International Ophthalmology Clinics. 2009 JAN; 49(1): 63-70.

643. Foster CS. Treatment of herpes simplex keratitis.  Refractive Eyecare.  2009 Jan; 13(1).

644. Quiñones K, Cervantes-Castañeda R, Hynes AY, Daoud YJ, Foster CS. Outcomes of Cataract Surgery in Children with Chronic Uveitis. J Cataract Refract Surg. 2009 Apr;35(4):725-31.

645. Doctor P, Bhat P, Foster CS. Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization. Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):118-26.

646. Iaccheri B, Papadaki T, Ko C, Fiore T, Zacharopoulos, Thadani S, Christen S, Foster CS. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis.  Acta Ophthalmol. 2009 Jun 2.

647. Cervantes-Castañeda R, Giuliari GP, Yilmaz T, McDonnell RE, Foster CS. Intravitreal Bevacizumab in Refractory Uveitic Macular Oedema: One year follow up. European Journal of Ophthalmology. 2009 Jul-Aug;19(4):622-9.

648. Gallagher MJ, Yilmaz T, Foster CS. Vogt-Koyanagi-Harada Syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surgery Lasers & Imaging. 2009 May-Jun;40(3): 345-347.

649. Foster CS. Vernal and Atopic Keratoconjunctivitis.  Refractive Eyecare.  2009 Jun 13(6).

650. Khan FH, Quinones K, Foster CS.  Ocular Allergy. Contemporary Ophthalmology. 2009 Jul 30; 8(14): 1-8.

Previous 50
   Next 50

  • Educational Audio

    Click here to listen to
     Uveitis and Steroid-Sparing Therapy

    Presented by C. Stephen Foster, MD, FACS, FACR

    Audio-Digest Ophthalmology Volume 56, Issue 15

  • Mia Resendes

  • Twitter Feed

  • Registration

    Click on Register

    Click on the Register link

    password email

    In the email you receive, click on the change password link.

    change password

    Change your password